Serum levels of CA125 are used to predict the risk of ovarian cancer diagnosis [5], although they can vary widely depending on the cancer subtype and stage, as well as physiological factors such as a patient’s menopausal status [6,7]. Here, MUC16 is linked to ovarian carcinoma.